Please Wait...

30 Bioclinica Scientific, Medical, Technology, and Clinical Development Experts Tapped to Present at Upcoming Industry Events

Leading voices will explore the growing role of science and technology in advancing drug and device development by surfacing new insights

September 25, 2017

Bioclinica®, the world-leading provider of specialized science and technology-enabled services supporting clinical research, today announces that 30 of its domain experts will present on a variety of topics addressing key aspects of the drug development lifecycle at upcoming industry conferences and webinars. Drawing on broad and deep industry experience across scientific, technology, medical, regulatory, data management, clinical operations, and therapeutic areas, Bioclinica speakers will share their knowledge of how life sciences companies are achieving improved quality, efficiency, accuracy, and patient safety by leveraging scientific- and technology-derived insights.

“Bioclinica has breadth and depth of knowledge within our organization and a legacy of innovation, which we are happy to share with others in our industry,”

- Bioclinica President and CEO John Hubbard, PhD

Bioclinica's experience spans three decades, thousands of clinical trials, and more than 150 U.S. FDA approvals. The Company serves all of the top 20 biopharmaceutical companies and leading Contract Research Organizations, as well as small and mid-sized companies worldwide.

Leading industry conferences and webinars through the end of 2017 will feature the following Bioclinica experts:



The Society for Clinical Data Management (SCDM) conference in Orlando:

  • David Kiger, Chief Commercial Officer, will chair a session on September 24, entitled, Unstructured and Structured Big Data Convergence for Bridging Clinical, Regulatory, and Commercialization.
  • Kristin Mauri, Global Head, Risk Based Monitoring, is one of the distinguished leaders in a workshop: A Data Manager's Guide to Risk Based Monitoring, on September 24.
  • Karen McPoyle, Director, Data Strategy and Solutions, will chair a session focused on achieving accelerated database lock through improved visualization of clean patient status entitled, Answering the Age Old Question, 'Are We There Yet?' on September 25.
  • Dr. Joby John, Senior Director, eHealth Operations, will chair a session, Improving Efficiencies and Effectiveness in Data Management of Oncology Studies, on September 26.
  • Jennifer Price, Senior Director, Clinical Solutions and SCDM Board Member, will moderate two key sessions at SCDM: the Regulatory Panel of the SCDM Business Meeting, and the Technology Innovation Award at the general meeting.





  • Sean Stanton, Senior Vice President Global Operations, Research Network, will share insights in a workshop, Going from Good to Great: Avoid the Most Common Pitfalls of Growing Your Site during the Global Site Solutions Summit (GSSS) in Boca Raton.
  • Lorie McClain will present a workshop: Focus on Site Financial Concerns - Transparency, Patient Support, and Reimbursement, at the Global Site Solutions Summit in Boca Raton, Florida on October 6.



  • Casey Ferrier, Director Supply Chain Management, will co-present with Paul Larochelle, Senior Manager, Clinical Asset Planning, Biogen, in a session, Implementing Technology with Success in Clinical Supply Management during the Annual Clinical Trials Supply East Coast in Princeton, New Jersey.




  • Herag Frankian, Program Director, RTSM, will co-present with Simi Nischal, Head of IRT, Target to Patient Supply Chain R&D, GlaxoSmithKline, on An Agile Approach to IRT: Enabling In-House Build and Support of Complex Trials, during the CBI IRT conference on October 27 in Philadelphia.



  • A scientific poster by Katarzyna Adamczuk, PhD; Beth Gorman, BS, CNMT; Maureen Runkle, BS, CNMT; Nicolas Pannetier, PhD; David Scott, PhD; and Joyce Suhy, PhD, entitled: Inter and Intra PET Scanner Variability in Multi-Center Clinical Trials Using the Hoffman Phantom, will be presentedat the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, Massachusetts.
  • Additionally at CTAD, Marieke Cajal, PhD, of Bioclinica Research Network, will present a poster entitled, Use of the CVLT-II as a pre-screening tool to reduce screen fails in MCI clinical trials.
  • Another poster will be presented at CTAD by Bioclinica Research Network’s Pamela Voccia on a new cognitive test showing the value of its use in clinical trials.


  • Martin Collyer, Managing Director and Chief Operating Officer, Patient Recruitment & Retention, will present a session during the Annual Patient Summit USA in Philadelphia, Pennsylvania, entitled, Setting Up Studies for Success.


  • A scientific paper authored by Tanja Schubert, PhD; Yannik Lhoste; Vanessa Di Cataldo; and Philippe Vergnaud, all of Bioclinica Lab, entitled: Quality Control Monitoring as Indicator of Stability in Bone and Cartilage Turnover Markers for Clinical Trials, will be presented at the American College of Rheumatology conference in San Diego, California.


  • Kristin Mauri, Global Head, Risk Based Monitoring, will present, Meeting of the Minds:  A Site, Sponsor and CRO Perspective, during CBI's Risk-Based Trial Management and Monitoring conference in Philadelphia. Also on November 3, she will present: ‘How Has Outsourcing Your RBM Changed over the Years?’


  • Tanja Schubert, PhD, and Vanessa Di Cataldo will make a poster presentation on behalf of Bioclinica Lab at the American College of Rheumatology’s Annual Meeting in the Biology and Pathology of Bone and Joint session.


  • Andrew Masters, Chief Technology Officer, will lead a roundtable at the Clinical Operations Strategy Meeting USA in Boston entitled: Becoming a Sponsor of Choice through Faster, More Accurate Site Payments and Budgeting.


  • Dave Kiger, Chief Commercial Officer, is among the distinguished speakers in a plenary discussion during MAGI's Clinical Research Conference West in San Francisco, California on November 13, entitled, Industry Consolidation and the Future of Clinical Research. He will also present a session on the following day in the Clinical Operations and Project Management Track: Visual Analytics for Study Management.


  • Mike Lange, Senior Director, Product Marketing, will present Too Big, Too Small, Just Right: Guidelines for Choosing a Clinical Technology Partner, during Partnerships in Clinical Trials, Europe in Amsterdam.



Participants in each of the above events will have an opportunity to ask Bioclinica experts questions following formal presentations. To schedule a briefing with a Bioclinica subject matter expert, submit an online Contact Form.  Visit events and webinars for the latest additions and updates and the Bioclinica Blog for insights from these and other thought leaders.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Ck out best-of-breed trial #technologies & services: #RTSM, #esource, #EDC, site & patient #payments, global site…
Bioclinica (Yesterday)
ICYMI: A discussion on recently released FDA draft guidance on assessment of blood pressure response in…
Bioclinica (Yesterday)
Our CIO & EVP Tech Gavin Nichols adds to #digitaltransformation discussion at #CMAsummit18 : W genomics & precision…
Bioclinica (3 days ago)
Greetings from Tokyo where @bioclinica's Japan. China & US locations R@DrugInfoAssn DIA Japan. Discuss region-spec…
Bioclinica (5 days ago)
Reminder to join us in a live #Xtalks webinar tomorrow 11/6 on Electronic Data Capture (EDC). Everything clinical t…
Bioclinica (2 weeks ago)
Meet with representatives of Bioclinica's Japan, China & US locations at DIA Japan. Angel Y., Hidenori Seshimo & Er…
Bioclinica (2 weeks ago)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner